CardioComm Solutions Enters Loan Agreement

Funding Rounds

▤ Summary

Toronto, Ontario--(Newsfile Corp. - July 22, 2024) - CardioComm Solutions, Inc. (TSXV: EKG) ("CardioComm" or the "Company"), a global medical provider of consumer heart monitoring and medical electrocardiogram ("ECG") software solutions, announces that it has entered into a revolving line-of-credit loan agreement with a company (the "Lender") controlled by Daniel Grima, a director of CardioComm dated as of July 22, 2024, representing additional available funding as needed of up to $500,000. The grant is subject to the provisions of the Companys Stock Option Plan, the policies of the TSX Venture Exchange and applicable securities laws.To learn more about CardioComms products and for further updates regarding HeartCheck ECG device integrations please visit the Companys websites at www.cardiocommsolutions.com and www.theheartcheck.com.About CardioComm SolutionsCardioComm Solutions patented and proprietary technology is used in products for recording, viewing, analyzing and storing electrocardiograms for diagnosis and management of cardiac patients. Products are sold worldwide through a combination of an external distribution network and a North American-based sales team. CardioComm Solutions has earned the ISO 13485 certification, is HIPAA compliant and holds clearances from the European Union (CE Mark), the USA (FDA) and Canada (Health Canada).Forward-Looking statementsThis release may contain certain forward-looking statements and forward-looking information with respect to the financial condition, results of operations and business of CardioComm Solutions and certain of the plans and objectives of CardioComm Solutions with respect to these items. The Company does not assume any obligation to update the forward-looking statements and forward-looking information contained in this release other than as required by applicable laws, including without limitation, Section 5.8(2) of National Instrument 51-102 (Continuous Disclosure Obligations).Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.To view the source version of this press release, please visit https://www.newsfilecorp.com/release/217411

$ Funding

$
Amount $363.3K Total raised
□
Date July 23, 2024 Announcement date
◎
Investors - Lead investors
▥
Company http://www.cardiocommsolutions.com Funded company

▥ Classifications

industries
HealthTech
applications
ERP Software

◇ AskAI Classifications

Labels
SaaS Healthcare IT Medical Device Software

▦ Linked Companies